H.R. 436, the “Protect Medical Innovation Act of 2011”
The Honorable Erik Paulsen
United States House of Representatives
Dear Representative Paulsen:
The U.S. Chamber of Commerce, the world’s largest business federation representing the
interests of more than three million businesses and organizations of every size, sector, and
region, strongly supports H.R. 436, the “Protect Medical Innovation Act of 2011,” which repeals
the onerous $20 billion excise tax on medical device manufacturers enacted as part of the health
care reform legislation.
This new 2.3 percent tax on virtually all medical devices beginning in 2013 will lead
to increased health care costs, undercutting one of the primary goals of health care reform. Further,
by driving up the cost of medical technology, the tax will undermine America’s global leadership
position in product innovation, clinical research, and patient care. In the current weak economy,
this tax will undermine the industry’s ability to create and maintain well paying jobs in the
United States and hinder the development of breakthrough treatments.
Finally, the tax singles out the medical technology industry to help pay for the cost of the
health care reform law. The Chamber opposes punitive taxes that target a particular industry,
sector, or income group.
The Chamber looks forward to working with you and your colleagues to advance H.R.
436 and repeal this onerous tax on the medical technology industry.
Sincerely,
R. Bruce Josten
cc: The Members of the House Committee on Ways and Means
Related Links
- National Sign-On Letter to Repeal the 1099 Provision in the Health Care Law
- Comments on Interim Final Rules for Pre-Existing Condition Insurance Plan Program
- Caroline L. Harris
- Comments to HHS on Insurance and Rating Rules Extension Request
- Guidance on 90-day Waiting Period Limitation (DOL Technical Release 2012-02)
- Comments on Institute of Medicine of the National Academies Survey on Essential Health Benefits
- National Sign-on Letter Urging Congress to Repeal Section 9006 of the "Patient Protection and Affordable Care Act"
- Comments to HHS on Reinsurance Rule Extension Request



